Glycogen Storage Disease Type V

Phase 2 trials (2)

• valproic acid
• triheptanoin

Phase 1 trials (1)

• ren001

Other trials (2)

• sucrose
• β-hydroxybuturate esters

Organization Involved with Phase 2 Indications (5)

• University of London
• Institut National de la Santé Et de la Recherche Médicale, France
• University of Copenhagen
• University of Paris
• The University of Texas, Dallas

Organization Involved with Phase 1 Indications (1)

• Reneo Pharma Ltd